[Total cholesterol mediates the effect of ABO blood group on coronary heart disease]

Ping Gong1, Sha Li, Liangyan Hu

  • 1Department of Cardiology, Wuhan University People's Hospital, Wuhan 430060, China.

Insights

Individuals with blood group A have a higher risk of coronary artery disease (CAD), with total cholesterol levels mediating 10.5% of this effect. This study explores the link between ABO blood type, lipids, and CAD risk.

Area of Science:

  • Cardiovascular Research
  • Genetics and Epidemiology

Background:

  • The relationship between ABO blood group and cardiovascular disease risk is complex and requires further elucidation.
  • Lipid profiles are established risk factors for coronary artery disease (CAD).

Purpose of the Study:

  • To investigate the association between ABO blood group, lipid profiles, and the risk of developing CAD.
  • To quantify the mediating effect of lipid levels on the relationship between ABO blood group and CAD using mediation analysis.

Main Methods:

  • A cohort of 898 patients undergoing coronary angiography was analyzed.
  • Patients were categorized by ABO blood group (O vs. non-O, A vs. non-A) and presence of CAD.
  • Statistical analyses, including mediation analysis, were performed to explore associations.

Main Results:

  • Blood group A was associated with higher total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) levels compared to non-A types.
  • CAD patients exhibited significantly higher TC and LDL-C, and lower high-density lipoprotein cholesterol (HDL-C) and ApoA I levels.
  • Blood group A and elevated TC were independently associated with increased CAD risk, with TC mediating 10.5% of the effect of blood group A on CAD.

Conclusions:

  • An association exists between ABO blood group, specifically blood group A, and increased risk of CAD.
  • Total cholesterol levels partially mediate the relationship between blood group A and the risk of coronary artery disease.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
857
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
983
The ABO Blood Group01:12

The ABO Blood Group

The ABO blood group system is a critical element of transfusion medicine, essential for determining blood compatibility in transfusions and organ transplants. It is based on specific antigens, or agglutinogens, present on the surface of red blood cells (RBCs) and corresponding antibodies, or agglutinins, in the blood plasma.
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
6.7K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.9K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
583